Trials / Completed
CompletedNCT01445626
A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 87 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will use retrospective data to evaluate the efficacy, safety, and re-injection interval of OZURDEX® in the treatment of macular oedema due to Retinal Vein Occlusion (RVO).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexamethasone intravitreal implant 0.7 mg | Dexamethasone intravitreal implant 0.7 mg was dosed previously according to general clinical practice. |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2011-10-04
- Last updated
- 2013-02-18
- Results posted
- 2013-02-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01445626. Inclusion in this directory is not an endorsement.